Created On: 2020-07-15
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 248329
The scientific collaboration is in the area of LPL gene therapy in humans including all research and development required for establishing a successful clinical LPL gene therapy protocol.
Licensed Product(s) means a Product using or made by a process using the Licensor Licensed Rights.
Description of Technology
U.S. 5,658,729 – Lipolipase Mutation 291, Implication for Coronary Artery Disease
U.S. SN 08/737,954 – Recombinant Viruses Preparation and use thereof in Gene Therapy
IPSCIO Record ID: 245877
Licensor transfers and assigns its right, title or interest in the Existing Patent Rights to Licensee.
AAV Vector is an adeno-associated virus vector composed of a transgene cassette with limited length, approximately 4.5 kb, flanked by an ITR DNA sequence.
FG Products are LPL Products, IL-10 Products and Nash Products.
IL-10 Product is a gene therapy product for the treatment of diseases and conditions caused by the deficiency or mutation of the IL-10 gene.
LPL Product is a gene therapy product for the treatment of diseases and conditions caused by lipoprotein lipase deficiency or mutation.
Nash Product is a gene therapy product for the treatment of non-alcoholic steatotic hepatitis.
The existing patent rights are for LPL variant therapeutics, and, IL-10 gene transfer to peripheral mononuclear cells, and, New method of treatment for non alcoholic steatotic hepatitis (NASH).
IPSCIO Record ID: 29073